Xuesong Liu

28.6k total citations · 5 hit papers
231 papers, 21.3k citations indexed

About

Xuesong Liu is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Xuesong Liu has authored 231 papers receiving a total of 21.3k indexed citations (citations by other indexed papers that have themselves been cited), including 114 papers in Molecular Biology, 51 papers in Oncology and 49 papers in Immunology. Recurrent topics in Xuesong Liu's work include PARP inhibition in cancer therapy (17 papers), Cell death mechanisms and regulation (16 papers) and DNA Repair Mechanisms (16 papers). Xuesong Liu is often cited by papers focused on PARP inhibition in cancer therapy (17 papers), Cell death mechanisms and regulation (16 papers) and DNA Repair Mechanisms (16 papers). Xuesong Liu collaborates with scholars based in China, United States and United Kingdom. Xuesong Liu's co-authors include Xiaodong Wang, Hua Zou, Jie Yang, Ronald Jemmerson, William J. Henzel, Dean P. Jones, Jiyang Cai, Tsung-I Peng, Ana Maria Ibrado and Kapil N. Bhalla and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Xuesong Liu

219 papers receiving 20.9k citations

Hit Papers

Induction of Apoptotic Program in Cell-Free Extracts: Req... 1996 2026 2006 2016 1996 1997 1997 1999 1997 1000 2.0k 3.0k 4.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xuesong Liu China 47 15.5k 3.8k 3.4k 2.3k 2.1k 231 21.3k
Maria Castedo France 51 11.9k 0.8× 4.9k 1.3× 3.8k 1.1× 2.1k 0.9× 2.1k 1.0× 108 19.0k
Kapil N. Bhalla United States 87 17.3k 1.1× 5.9k 1.5× 2.8k 0.8× 2.2k 1.0× 1.7k 0.8× 378 26.0k
Emily H. Cheng United States 48 12.6k 0.8× 2.6k 0.7× 2.1k 0.6× 2.5k 1.1× 2.3k 1.1× 94 16.4k
Yuri Lazebnik United States 33 14.7k 1.0× 3.7k 1.0× 3.4k 1.0× 2.2k 1.0× 2.0k 1.0× 53 19.3k
David M. Hockenbery United States 50 10.5k 0.7× 3.6k 1.0× 3.2k 1.0× 2.1k 0.9× 1.3k 0.6× 124 16.7k
Steven Grant United States 79 16.7k 1.1× 6.3k 1.6× 2.2k 0.6× 2.3k 1.0× 2.1k 1.0× 451 23.2k
Timothy D. Veenstra United States 88 17.3k 1.1× 4.2k 1.1× 2.0k 0.6× 2.4k 1.0× 1.9k 0.9× 401 28.5k
B. Mark Evers United States 73 10.5k 0.7× 4.3k 1.1× 1.6k 0.5× 3.5k 1.5× 2.0k 1.0× 362 17.6k
Philippe Marchetti France 62 9.9k 0.6× 2.4k 0.6× 2.3k 0.7× 1.6k 0.7× 1.4k 0.7× 177 16.1k
Yi Li China 65 9.7k 0.6× 5.4k 1.4× 3.5k 1.0× 3.2k 1.4× 1.5k 0.7× 695 19.1k

Countries citing papers authored by Xuesong Liu

Since Specialization
Citations

This map shows the geographic impact of Xuesong Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuesong Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuesong Liu more than expected).

Fields of papers citing papers by Xuesong Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuesong Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuesong Liu. The network helps show where Xuesong Liu may publish in the future.

Co-authorship network of co-authors of Xuesong Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Xuesong Liu. A scholar is included among the top collaborators of Xuesong Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuesong Liu. Xuesong Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yuhua, et al.. (2025). Invasive aspergillosis in critically ill patients with diabetes mellitus: a systematic review and meta-analysis. BMC Infectious Diseases. 25(1). 141–141. 3 indexed citations
2.
Liu, Xuesong, et al.. (2024). 24-epibrassinolide as a multidimensional regulator of rice (Oryza sativa) physiological and molecular responses under isoproturon stress. Ecotoxicology and Environmental Safety. 281. 116575–116575. 4 indexed citations
3.
Yang, Haotian, Yongping Chen, Zhiqiang Wang, et al.. (2024). Dexmedetomidine affects the NOX4/Nrf2 pathway to improve renal antioxidant capacity. Journal of Pharmacy and Pharmacology. 76(7). 851–860. 3 indexed citations
4.
Zhang, Yiwei, Yong Chen, Ping Shao, et al.. (2024). Baicalin derivative dynamically cross-linked natural polysaccharide hydrogel for diabetic wound healing. Chemical Engineering Journal. 497. 154803–154803. 19 indexed citations
5.
Feng, Qiuting, et al.. (2024). Machine learning-based CT radiomics approach for predicting occult peritoneal metastasis in advanced gastric cancer preoperatively. Clinical Radiology. 80. 106727–106727. 3 indexed citations
6.
Huang, Yan, Xuesong Liu, Chensihan Huang, et al.. (2023). Associations of Oral Contraceptive Use With Cardiovascular Disease and All‐Cause Death: Evidence From the UK Biobank Cohort Study. Journal of the American Heart Association. 12(16). e030105–e030105. 13 indexed citations
8.
Wang, Shixiang, Yi Xiong, Longfei Zhao, et al.. (2021). UCSCXenaShiny: an R/CRAN package for interactive analysis of UCSC Xena data. Bioinformatics. 38(2). 527–529. 97 indexed citations
9.
Wang, Shixiang, Huimin Li, Minfang Song, et al.. (2021). Copy number signature analysis tool and its application in prostate cancer reveals distinct mutational processes and clinical outcomes. PLoS Genetics. 17(5). e1009557–e1009557. 73 indexed citations
11.
Wang, Shixiang, Ziyu Tao, Tao Wu, & Xuesong Liu. (2020). Sigflow: an automated and comprehensive pipeline for cancer genome mutational signature analysis. Bioinformatics. 37(11). 1590–1592. 29 indexed citations
12.
Wang, Shixiang & Xuesong Liu. (2019). The UCSCXenaTools R package: a toolkit for accessing genomics data from UCSC Xena platform, from cancer multi-omics to single-cell RNA-seq. The Journal of Open Source Software. 4(40). 1627–1627. 55 indexed citations
13.
Liu, Xuesong, Matthew Genet, Jenna E. Haines, et al.. (2015). ZBTB7A Suppresses Melanoma Metastasis by Transcriptionally Repressing MCAM. Molecular Cancer Research. 13(8). 1206–1217. 34 indexed citations
14.
González‐Billalabeitia, Enrique, Nina Seitzer, Su Jung Song, et al.. (2014). Vulnerabilities of PTENTP53 -Deficient Prostate Cancers to Compound PARP–PI3K Inhibition. Cancer Discovery. 4(8). 896–904. 80 indexed citations
15.
Palma, Joann P., Yichun Wang, Luis E. Rodrı́guez, et al.. (2009). ABT-888 Confers Broad In vivo Activity in Combination with Temozolomide in Diverse Tumors. Clinical Cancer Research. 15(23). 7277–7290. 111 indexed citations
16.
Liu, Xuesong, Edward K. Han, Mark G. Anderson, et al.. (2009). Acquired Resistance to Combination Treatment with Temozolomide and ABT-888 Is Mediated by Both Base Excision Repair and Homologous Recombination DNA Repair Pathways. Molecular Cancer Research. 7(10). 1686–1692. 77 indexed citations
17.
Zhu, Gui‐Dong, Jianchun Gong, Viraj B. Gandhi, et al.. (2007). Design and synthesis of pyridine–pyrazolopyridine-based inhibitors of protein kinase B/Akt. Bioorganic & Medicinal Chemistry. 15(6). 2441–2452. 58 indexed citations
18.
Liu, Xuesong, Yanming Huang, Marijke Pellens, et al.. (2005). Nitric oxide inhalation decreases myocardial injury in a porcine model of cardiac ischemia and reperfusion. Circulation. 112(17). 1 indexed citations
19.
De, Suvranu, Yanming Huang, Xuesong Liu, et al.. (1999). Evaluation of the biocompatibility of two new diamond-like stent coatings (Dylyn) in a porcine coronary stent model. European Heart Journal. 20. 271–271. 1 indexed citations
20.
De, Suvranu, et al.. (1999). Impact of surface electrochemical polishing on stent performance: insights from a porcine coronary model. European Heart Journal. 20. 273–273. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026